A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease

NCT00445432 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

BIOLOGICAL: adalimumab
OTHER: Placebo

Sponsor

Abbott

Collaborators

[object Object]